Accéder au contenu
Merck

The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT.

Anticancer research (2015-01-01)
Robert Fuchs, Gert Schwach, Anika Stracke, Nathalie Meier-Allard, Markus Absenger, Elisabeth Ingolic, Helga Susanne Haas, Roswitha Pfragner, Anton Sadjak
RÉSUMÉ

Medullary thyroid carcinoma (MTC) is a tumor associated with poor prognosis since it exhibits high resistance against conventional cancer therapy. Recent studies have shown that quinazolines exhibit a pro-apoptotic effect on malignant cells. The aim of the present study was to elucidate whether MTC cells are affected by quinazolines, in particular prazosin. Proliferation, apoptosis and cell morphology of the MTC cell line TT were analyzed by WST-1 assay, caspase 3/7 activation tests and microscopy. Fibroblasts were used as control for non-malignant cells. Prazosin potently inhibited the growth of TT cells, induced apoptosis and caused vacuolization, as well as needle-like filopodia. Fibroblasts were affected by prazosin in the same way as MTC cells. MTC cells are responsive to prazosin treatment similar to other malignancies. The fact that fibroblasts also respond to prazosin further highlights the importance to identify the unknown pro-apoptotic target of quinazolines.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Phenylacetic acid, 99%
Sigma-Aldrich
Prazosin hydrochloride, ≥99.0% (HPLC)
Sigma-Aldrich
Phenylacetic acid, ≥99%, FCC, FG
USP
Prazosin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Prazosin hydrochloride, European Pharmacopoeia (EP) Reference Standard
TT, 92050721